Home>Topics>Finance>Technology>Biotechnology

Biotechnology

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
  1. Puma Biotechnology : Who Are They? What Happened? And, Where Are They Going?

    Headlines

    Thu, 21 Aug 2014

    By Sam Ross : Puma Biotech , a small development stage biopharmaceutical company, recently ..... what happened, and they are not alone. Company Description Puma Biotechnology , Inc (NYSE: PBYI ) is a neat little development stage biopharmaceutical

  2. New Morningstar Analyst Report for Myriad Genetics Inc

    Stock Reports

    Thu, 21 Aug 2014

    other prognostic tests. The firm also offers biomarker discovery and companion diagnostic services to pharmaceutical and biotechnology companies. The market for BRCA testing has become particularly competitive following the U.S. Supreme Court decision

  3. Ilumina collaborates with members of Big Pharma on molecular diagnostics

    Headlines

    Thu, 21 Aug 2014

    Ilumina (NASDAQ: ILMN ) has formed collaborative partnerships with AstraZeneca (NYSE: AZN ), Janssen Biotech (NYSE: JNJ ) and Sanofi (NYSE: SNY ) to develop a universal next-generation sequencing (NGS) system focused on oncology

  4. Quite A Comeback For This Momentum ETF

    Headlines

    Thu, 21 Aug 2014

    by sharp retrenchments in biotechnology , Internet and social media ..... SOCL ) and the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB ) to ominous ..... decline was not bad compared to biotech , Internet and social media ..... stocks and has only scant biotech Complete Story »

  5. MannKind Corporation: Back To The Fundamentals

    Headlines

    Wed, 20 Aug 2014

    By George Rho : Developmental-stage biotechnology stocks are by their very nature story stocks, driven by news, hope, fear, hype, uncertainty, emotions, and expectations

  6. Solazyme Gains A Partner For Specialty Soap Production

    Headlines

    Wed, 20 Aug 2014

    oils and bioproducts company named Solazyme ( SZYM ) . By customizing the oil composition of heterotrophic microalgae, the biotechnology company has unlocked the ability to design tailored oils which can compete and improve upon their vegetable-based and

  7. Risk And Reward Seem Pretty Balanced At Seattle Genetics

    Headlines

    Tue, 19 Aug 2014

    By Stephen Simpson, CFA : Oncology biotech Seattle Genetics (NASDAQ: SGEN ) has ..... or ADC) compounds, not to mention biotech enthusiasm in general, before getting caught up in the great biotech washout and fears tied to the safety of

  8. Reasons I Abandoned My Long Position In Cytori

    Headlines

    Tue, 19 Aug 2014

    currently practicing Child Psychiatry, also board certified in Pediatrics) and part-time investor. I invest in several biotech companies and was invested in Cytori Therapeutics (NASDAQ: CYTX ) for over a year until recently. I look for the combination

  9. Can You Handle Risk? With A Dozen Clinical Trials, Exelixis Has Strong Upside Potential

    Headlines

    Tue, 19 Aug 2014

    Christopher F. Davis : As a PhD-level epidemiologist and market analyst, there is no sector more interesting to me than biotech . I have opined on several of these names in the past. Those of you who follow my work know that I search for companies that

  10. An Update On A Couple Of Small Biotech Plays

    Headlines

    Tue, 19 Aug 2014

    philosophy about investing in the small biotech space by now. This arena is simply different ..... that there will be many misses within the biotech portion of your portfolio. However ..... readers on a couple of my favorite small biotech stocks and what lies ahead for both

« Prev12345Next »
Content Partners